How Prasad was paid
$272,964 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Other | Total |
|---|---|---|---|
| Deepika VuppalanchiFormer Chief Executive Officer | $150,894 | $5,688 | $156,582 |
| Sandeep AllamFormer President and Chairman | $62,553 | $510 | $63,063 |
| Priya PrasadChief Operating Officer, Chief Financial Officer | $265,384 | $7,580 | $272,964 |
What changed and why
- $273K$272,964 was Priya Prasad’s total compensation for 2025, compared with $171,291 in 2024.
- $42,700$42,700 of Prasad’s salary represented service as interim CEO, with $10,124 in deferred salary.
- $6,100$6,100 monthly interim CEO allowance was provided to Prasad beginning June 16, 2025.
- $122K$122,000 shares were awarded to Prasad, vesting upon Board-determined milestones.
- $0$0 annual incentive bonuses were awarded for 2025 based on the Board’s performance review.
- 4%4% of participant compensation is matched under the Company’s 401(k) plan, subject to IRS limits.
Other Syra Health proxy statements
- 2025 proxy statement
Deepika Vuppalanchi paid $282,807 (-12% on the year).
Filed Sep 19, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.